心臟輔助設備市場規模、佔有率和成長分析（按產品類型、部位、模式和地區分類）－2026-2033年產業預測

全球心臟輔助設備市場規模預計在 2024 年達到 42.5 億美元，從 2025 年的 48.3 億美元成長到 2033 年的 135 億美元，在預測期（2026-2033 年）內複合年成長率為 13.7%。

全球心臟輔助設備市場涵蓋用於支援或取代心臟功能、維持心臟衰竭或心臟病患者正常血液循環的醫療設備。這些設備對於治療末期心臟衰竭、心源性休克、心血管手術後復健以及等待或不適合心臟移植的患者至關重要。心血管疾病盛行率的上升、人口老化以及技術進步是推動市場成長的主要因素。小型化、耐用性和電池壽命方面的創新提高了設備的效率和易用性，而微創植入技術則擴大了患者的覆蓋範圍。在成熟企業和新興企業競爭激烈的市場環境中，持續的研究與合作對於推動市場發展和改善患者照護效果至關重要。

全球心臟輔助設備市場促進因素

心血管疾病，尤其是冠狀動脈疾病的日益流行，是全球心臟輔助設備市場的主要驅動力。不健康的飲食習慣、久坐的生活方式以及生活方式的整體改變等因素，正在推動全球範圍內此類疾病的發病率上升。隨著越來越多的人面臨心血管健康方面的挑戰，對創新心臟輔助技術的需求持續成長。這一趨勢凸顯了為心臟疾病患者提供有效解決方案的迫切需求，從而推動了心臟輔助設備領域的進一步發展和投資。

限制全球心臟輔助設備市場的因素

全球心臟輔助設備市場面臨許多限制因素，這些限制因素源自於這些複雜系統固有的各種技術挑戰。設備的正確植入、管理和持續監測需要高技能人員和專門的基礎設施，而並非所有醫療機構都具備這些條件。這種技術複雜性，加上醫療專業人員學習曲線陡峭，可能會阻礙心臟輔助技術的廣泛應用。因此，由於醫療機構難以獲得足夠的培訓和資源來有效利用這些關鍵設備，市場成長潛力可能受到限制。

全球心臟輔助設備市場趨勢

全球心臟輔助設備市場正呈現以患者為中心的設計趨勢，強調改善心臟病患者的使用者體驗和生活品質。製造商越來越重視舒適性和便攜性，這推動了更小巧、更安靜、植入併發症更少的設備的發展。這種設計理念不僅滿足了患者的需求，也促進了創新，促使企業致力於研發能夠無縫融入日常生活的設備。隨著人們對患者偏好的認知不斷提高，預計市場將朝著更有效、更人性化的心臟輔助解決方案方向發展。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管環境
• 案例研究
• 技術進步

全球心臟輔助設備市場規模（按產品類型和複合年成長率分類）（2026-2033 年）

• 經人工心臟（TAH）
• 主動脈內球囊反搏幫浦（IABP）
• 心室輔助裝置（VAD）

全球心臟輔助設備市場規模（按安裝地點和複合年成長率分類）（2026-2033 年）

• 右心室輔助裝置（RVAD）
• 左心室輔助裝置（LVAD）
• 體外心室輔助裝置（VAD）
• 雙心室輔助裝置（Bi-VAD）

全球心臟輔助設備市場規模（按模式類型和複合年成長率分類）（2026-2033 年）

• 經皮
• 可植入式

全球心臟輔助設備市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 門診手術中心
• 其他

全球心臟輔助設備市場規模（按地區分類）及複合年成長率（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Berlin Heart GmbH（Germany）
• Biotronik SE & Co. KG（Germany）
• ReliantHeart Inc.（United States）
• SynCardia Systems, LLC（United States）
• Teleflex Incorporated（United States）
• Levitronix GmbH（Switzerland）
• Jarvik Heart, Inc.（United States）
• Sunshine Heart, Inc.（United States）
• CardiacAssist, Inc.（TandemLife）（United States）
• CorWave SA（France）
• Evaheart, Inc.（Japan）
• FineHeart SA（France）
• Windmill Cardiovascular Systems, Inc.（United States）
• CARMAT（France）
• Calon Cardio-Technology Ltd.（United Kingdom）
• NewHeart Medical Devices, LLC（United States）
• MiTiHeart Corporation（United States）
• CircuLite, Inc.（United States）
• CardioBridge GmbH（Germany）

結論與建議

Global Cardiac Assist Devices Market size was valued at USD 4.25 Billion in 2024 and is poised to grow from USD 4.83 Billion in 2025 to USD 13.5 Billion by 2033, growing at a CAGR of 13.7% during the forecast period (2026-2033).

The global Cardiac Assist Devices market encompasses medical equipment engineered to support individuals facing heart failure or cardiac issues by assisting or replacing heart function to maintain proper blood circulation. These devices are vital for managing conditions such as end-stage heart failure, cardiogenic shock, and recovery post-cardiac surgery. They cater to patients awaiting heart transplants or those unsuitable for such procedures. The market's growth is bolstered by the rising prevalence of cardiovascular diseases, an aging population, and advancements in technology. Innovations in miniaturization, durability, and battery life boost efficiency and user-friendliness, while minimally invasive implantation techniques broaden patient eligibility. With a competitive landscape of established and emerging players, ongoing research and collaborations are essential for market evolution and improved patient care outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Assist Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Assist Devices Market Segments Analysis

Global Cardiac Assist Devices Market is segmented by Product Type, Placement Location, Modality Type, End User and region. Based on Product Type, the market is segmented into Total Artificial Heart (TAH), Intra-Aortic Balloon Pumps (IABP) and Ventricular Assist Devices (VAD). Based on Placement Location, the market is segmented into Right Ventricular Assist Device (RVAD), Left Ventricular Assist Device (LVAD), External Ventricular Assist Device (VAD) and Bi-Ventricular Assist Device (Bi-VAD). Based on Modality Type, the market is segmented into Transcutaneous and Implantable. Based on End User, the market is segmented into Hospital, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Assist Devices Market

The increasing prevalence of cardiovascular diseases, particularly coronary artery disease, significantly propels the global Cardiac Assist Devices market. Factors such as unhealthy dietary habits, sedentary lifestyles, and overall lifestyle changes have led to a heightened incidence of these conditions worldwide. As more individuals face the challenges associated with cardiovascular health, the demand for innovative cardiac assist technologies continues to grow. This trend underscores the need for effective solutions to assist patients suffering from heart-related ailments, thereby further stimulating advancements and investments within the cardiac assist devices sector.

Restraints in the Global Cardiac Assist Devices Market

The Global Cardiac Assist Devices market faces significant constraints due to various technical challenges inherent in these advanced systems. Proper implantation, management, and ongoing monitoring of the devices demand a highly skilled workforce and specialized infrastructure, which may not be readily available in all healthcare settings. These technical complexities, combined with steep learning curves for healthcare providers, can hinder the widespread adoption of cardiac assist technologies. As a result, the market's growth potential could be limited, as healthcare institutions grapple with ensuring adequate training and resources to effectively utilize these critical devices.

Market Trends of the Global Cardiac Assist Devices Market

The Global Cardiac Assist Devices market is witnessing a significant trend towards patient-centric design, emphasizing the enhancement of user experience and quality of life for individuals with cardiac conditions. Manufacturers are increasingly prioritizing comfort and portability, leading to the development of smaller, quieter devices that minimize complications during implantation. This focus on design not only caters to patient needs but also drives innovation, as companies seek to create devices that integrate seamlessly into daily life. As awareness of patient preferences continues to grow, the market is likely to evolve in favor of more effective and user-friendly cardiac assist solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Cardiac Assist Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Total Artificial Heart (TAH)
• Intra-Aortic Balloon Pumps (IABP)
• Ventricular Assist Devices (VAD)

Global Cardiac Assist Devices Market Size by Placement Location & CAGR (2026-2033)

• Market Overview
• Right Ventricular Assist Device (RVAD)
• Left Ventricular Assist Device (LVAD)
• External Ventricular Assist Device (VAD)
• Bi-Ventricular Assist Device (Bi-VAD)

Global Cardiac Assist Devices Market Size by Modality Type & CAGR (2026-2033)

• Market Overview
• Transcutaneous
• Implantable

Global Cardiac Assist Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospital
• Ambulatory Surgical Centers
• Others

Global Cardiac Assist Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Placement Location, Modality Type, End User)
  • US
  • Canada
• Europe (Product Type, Placement Location, Modality Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Placement Location, Modality Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Placement Location, Modality Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Placement Location, Modality Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Berlin Heart GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReliantHeart Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SynCardia Systems, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Levitronix GmbH (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jarvik Heart, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sunshine Heart, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardiacAssist, Inc. (TandemLife) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CorWave SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evaheart, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FineHeart SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Windmill Cardiovascular Systems, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CARMAT (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Calon Cardio-Technology Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NewHeart Medical Devices, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiTiHeart Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CircuLite, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioBridge GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations